Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02992964
Recruitment Status : Active, not recruiting
First Posted : December 14, 2016
Last Update Posted : February 15, 2021
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Daniel Morgenstern, The Hospital for Sick Children

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021